Business Standard

Celestial Biolabs Share Price

Know More
BSENSE

2.02 0.00 (0.00%)

11th Mar 2020
Stock not traded

BSE : 532871

NSE : CELESTIAL

Sector : Health care

ISIN Code : INE221I01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 11-Mar-2020

Market Cap (₹ Cr)

5

Traded Value (₹ Cr)

0.00

Volume (Shares)

124

Face Value (₹)

10

52-Week High (₹)

2.02

52-Week High Date

11-Mar-2020

52-Week Low (₹)

0.00

52-Week Low Date

Invalid date

All Time High (₹)

78.25

All Time High Date

04-Jan-2008

All Time Low (₹)

1.99

All Time Low Date

20-Feb-2020

Celestial Biolabs Ltd

CELESTIAL LABS LIMITED was incorporated as a Private Limited Company on November 19 1997 as 'Celestial Technologies Private Limited'. Mr. Rajani Kanth Katragadda and Mr. Vijay Marur have promoted the company. The company was later converted into a Public Limited Company under the name 'Celestial Technologies Limited' on December 6 1999 and has been subsequently renamed as 'CELESTIAL LABS LIMITED' effective from February 13 2004. The present promoter of the company is Mr. Aditya Narayan Singh. The Original promoters sold their holding to the present promoter on 7.11.1998.The company has received ISO 9001-2000 certificate. The company has been providing customized enterprise solutions bioinfor...
Read More

Celestial Biolab Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Celestial Biolabs Limited</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L72200TG1997PLC028374</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>8.87</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SADA NAGA LATHA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: cs@celestialbiolabs.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: ARVIND DEVIPRASAD SHARMA <br/> Designation: CFO <br/> EmailId: cs@celestialbiolabs.com</div> </div> <div> <br/> Date: 30/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Celestial Biolabs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

5

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]1.17
P/B Ratio (₹) [C]1.73

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

2.02

2.02

Week Low/High (₹)

0.00

2.02

Month Low/High (₹)

0.00

2.02

Year Low/High (₹)

0.00

2.02

All time Low/High (₹)

1.99

78.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week%%-0.70-0.81%
1 Month%%3.633.72%
3 Month%%8.699.14%
6 Month%%12.7913.79%
1 Year%%20.7324.10%
3 Year%%51.2953.97%

Company Info

Company Information

Managing Director : A N Singh

Director : Padma Singh

Director : Jeetainder Roy Gour

Company Secretary : Sada Naga Latha

Executive Director & CEO : Dattatreya Rao

Registered Office: Plot No 59 Road No 12, TSIIC Tech Park IDA Nacharam,Hyderabad,Telangana-500076 Ph: 91-40-65552697/64565544

Email:cs@celestialbiolabs.com

URL:http://www.celestialbiolabs.com

FAQs about Celestial Biolabs Ltd

1. What's the Celestial Biolabs Ltd share price today?
Celestial Biolabs Ltd share price was Rs 2.02 at close on 11th Mar 2020. Celestial Biolabs Ltd share price was up by 0.00% over the previous closing price of Rs 2.02. Celestial Biolabs Ltd share price trend:

  • Last 1 Month: Celestial Biolabs Ltd share price moved up by % on _
  • Last 3 Months: Celestial Biolabs Ltd share price moved up by % on _
  • Last 12 Months: Celestial Biolabs Ltd share price moved up by % on _
  • Last 3 Years: Celestial Biolabs Ltd price moved up by % on _


2. How can I quickly analyse the performance of the Celestial Biolabs Ltd stock?
The performance of the Celestial Biolabs Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is 1.73
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Celestial Biolabs Ltd stock is Rs 0.00


3. What is the market cap of Celestial Biolabs Ltd?
Celestial Biolabs Ltd has a market capitalisation of Rs 5 crore.


4. What is Celestial Biolabs Ltd's 52-week high/low share price?
The Celestial Biolabs Ltd’s 52-week high share price is Rs 2.02 and 52-week low share price is Rs 0.00.


5. Is the Celestial Biolabs Ltd profitable?
On a consolidated basis, Celestial Biolabs Ltd reported a loss of Rs -0.03 crore on a total income of Rs 0.04 crore for the quarter ended 2023. For the year ended Dec 2023, Celestial Biolabs Ltd had posted a loss of Rs -0.04 crore on a total income of Rs 0.04 crore.


6. Which are Celestial Biolabs Ltd’s peers in the Health care sector?
Celestial Biolabs Ltd’s top 5 peers in the Health care sector are Unjha Formul., Kobo Biotech, Bacil Pharma.


7. Who owns how much in Celestial Biolabs Ltd?
Key changes to the Celestial Biolabs Ltd shareholding are as follows:

  • Promoter holding in Celestial Biolabs Ltd has gone up to 26.07 per cent as of Mar 2024 from 26.07 per cent as of Jun 2023.